↓ Skip to main content

ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
12 X users

Citations

dimensions_citation
193 Dimensions

Readers on

mendeley
125 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway
Published in
Journal of Experimental & Clinical Cancer Research, April 2019
DOI 10.1186/s13046-019-1156-5
Pubmed ID
Authors

Qi Zhang, Sihong Lu, Tianfu Li, Liang Yu, Yunjian Zhang, Huijuan Zeng, Xueke Qian, Jiong Bi, Ying Lin

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 125 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 12%
Researcher 14 11%
Student > Ph. D. Student 11 9%
Student > Master 9 7%
Student > Doctoral Student 4 3%
Other 13 10%
Unknown 59 47%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 22 18%
Medicine and Dentistry 19 15%
Immunology and Microbiology 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Engineering 3 2%
Other 10 8%
Unknown 61 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 August 2022.
All research outputs
#4,212,785
of 25,795,662 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#229
of 2,438 outputs
Outputs of similar age
#80,430
of 364,800 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#8
of 74 outputs
Altmetric has tracked 25,795,662 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,438 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,800 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.